Cite

HARVARD Citation

    Cao, L. et al. (2016). A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain. NeuroReport. 27 (6), p. . [Online]. 
  
Back to record